MetaCap

Who Owns Cellectis S.A. Stock?

NASDAQ: CLLSHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.9209-0.0789 (-7.89%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
13.35%
Institutional holders
35
  • Institutions 13.3%
  • Insiders 0.0%
  • Public and other 86.7%

Who owns Cellectis S.A. stock?

Institutional investors own about 13.3% of Cellectis S.A.'s shares, spread across 35 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 0.00% of CLLS.

The largest institutional holders are B Group, Inc. (4.55%), Long Focus Capital Management, LLC (3.80%) and UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC (3.60%). Together, the top 10 institutions control 13.0% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their CLLS positions and 2 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of CLLS

Cellectis S.A. top institutional holders
InstitutionShares% HeldChange
B Group, Inc. 3.28M4.55%0.0%
Long Focus Capital Management, LLC2.74M3.80%0.0%
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC2.60M3.60%-1.8%
Blackrock Inc.246.41K0.34%+9.3%
Nomura Asset Management International Inc226.88K0.31%0.0%
Morgan Stanley86.37K0.12%+1.1%
LPL Financial LLC85.59K0.12%+1.4%
UBS Group AG47.83K0.07%+41.0%
BNP Paribas Financial Markets37.50K0.05%-6.5%
Walleye Partners, LLC35.00K0.05%+100.0%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of CLLS

Cellectis S.A. top fund holders
FundShares% Held
iShares Trust-iShares Biotechnology ETF246.41K0.34%
Delaware Group Equity Funds IV-Nomura Healthcare Fund226.88K0.31%
Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund1.95K0.00%

Frequently asked questions

Who is the largest shareholder of Cellectis S.A.?

B Group, Inc. is the largest institutional shareholder of CLLS, owning 4.55% of shares outstanding (3.28M shares) as of its latest 13F filing.

What percentage of Cellectis S.A. is owned by institutions?

Institutions own about 13.3% of CLLS shares and 13.3% of the public float.

How much of Cellectis S.A. do insiders own?

Insiders, such as officers and directors, own about 0.00% of CLLS shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related